Martin Shkreli starts YouTube live stream a day after leaving jail

Tilles also thanked Shkreli “for helping us build Turing Pharmaceuticals into the dynamic research-focused company it is today”, a reference to Shkreli’s after-the-fact claim that he needed to raise Daraprim’s price so much to fund research on other drugs.

Shkreli, who is charged with securities fraud and conspiracy, having been arrested on Thursday, used Twitter on Saturday to say: “I am confident I will prevail”.

Shkreli recently became the CEO of a second company, KaloBios Pharmaceuticals, Inc., based in South San Francisco, California.

The allegations concern Shkreli’s activities from 2009-2014 at another company and two hedge funds, prior to his career at Turing. “Mr. Shkreli expects to be fully vindicated”, his attorneys said in a statement Thursday.

The federal authorities alleged that he committed securities fraud and operated his companies like a Ponzi scheme for a period of five years, when he was still working as CEO of Retrophin and hedge fund manager of MSMB Capital and MSMB Healthcare.

Earlier this year, Shkreli was widely criticized for his company’s decision to raise the price of a life-saving AIDS drug from $13 to $750 per pill. A spokeswoman for prosecutors declined to comment.

The indictment said Shkreli made false representations to MSMB investors to draw in $3 million in investments.

Turing, with offices in NY and Switzerland, spent $55 million in August for the USA rights to sell Daraprim.

However, the price of KaloBios Pharmaceuticals shares surged from around $2 to above $40 after the struggling cancer drug developer named Shkreli chairman and CEO in November.

According to Shkreli, he is finding an audience.

Wearing a purple PBS T-shirt and plaid pajama bottoms, Shkreli, 32, responded to commenters on the stream. “We try hard to make sure that our money is coming from places we’re comfortable with”, its spokesman said.

Questcor raised the price in 2007 because Acthar was no longer profitable, according to Mallinckrodt, and since it was acquired Mallinckrodt says its price increases have been in line with or below inflation.

Turing, a privately held company in NY, said that Ron Tilles, its chairman, would step in as interim chief executive.